Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000, C544S262000, C544S265000, C514S262100, C514S263230, C514S263300
Reexamination Certificate
active
07977345
ABSTRACT:
A compound for modulating kinase activity according to Formula I,or a pharmaceutically acceptable salt thereof, Wherein J1, J2, J3, R2, J4, Z, Ar and R3are as defined in the specification, compositions thereof, and methods of use thereof.
REFERENCES:
patent: 6448261 (2002-09-01), Bakthavatchalam et al.
patent: 7439246 (2008-10-01), Borzilleri et al.
patent: 2004/0053908 (2004-03-01), Funahashi et al.
patent: 0795556 (1997-09-01), None
patent: 1411046 (2004-04-01), None
patent: 95/19774 (1995-07-01), None
patent: WO 2004/018473 (2004-04-01), None
patent: 2005/005389 (2005-01-01), None
Vippagunta et. al. (Advanced Drug Delivery Reviews, 2001, 48, pp. 3/26).
Shealy et al., “v-Triazolo[4,5-d]pyrimidines. II. O-Substituted Derivatives of 8-Azaguanine and 8-Azahypoxanthine,” J. Organic Chemistry, vol. 27, pp. 4518-4523 (1962).
Laufer et al., “Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors,” J. Med. Chem., 48 (3): 710-722 (Feb. 10, 2005).
Myers et al., “The preparation and SAR of 4-(-anilino)-quinazolines: p56Ick and EGF-R tyrosine kinase activity,” Bioorg. Med. Chem. Lett., 7 (4): 417-420 (Feb. 18, 1997).
Norman et al., “4-(Heteroarylthio)-2-byphenylyltetrazoles as nonpeptide angiotensin II antagonists,” J. Med. Chem., 38 (23): 4670-4678 (Nov. 10, 1995).
Bannen Lynne Canne
Chan Diva Sze-Ming
Dalrymple Lisa Esther
Jammalamadaka Vasu
Khoury Richard George
Berven Heidi M.
Exelixis Inc.
Honigman Miller Schwartz and Cohn
Moore Susanna
O'Brien Jonathan P.
LandOfFree
c-MET modulators and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with c-MET modulators and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and c-MET modulators and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2658452